Clinical Study of Anti-CLL1-CD33-NKG2D Bicephali CAR-T for Relapsed/Refractory Acute Myeloid Leukemia
Clinical trial NCT07370064 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07370064
- Sponsor
- Xuzhou Medical University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-31
- Primary completion
- 2028-01-31
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.